491 related articles for article (PubMed ID: 16716479)
1. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Sarandol A; Kirli S; Akkaya C; Ocak N; Eroz E; Sarandol E
J Psychopharmacol; 2007 Nov; 21(8):857-63. PubMed ID: 17715203
[TBL] [Abstract][Full Text] [Related]
3. Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia.
Sarandöl E; Safak O; Dirican M; Uncu G
Clin Biochem; 2004 Nov; 37(11):990-6. PubMed ID: 15498527
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.
Kotan VO; Sarandol E; Kirhan E; Ozkaya G; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1284-90. PubMed ID: 21515329
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase activity in glomerulonephritic patients.
Gullulu M; Kahvecioglu S; Dirican M; Akdag I; Ocak N; Demircan C; Dilek K; Ersoy A; Yavuz M; Yurtkuran M
Ren Fail; 2007; 29(4):433-9. PubMed ID: 17497465
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
9. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
[TBL] [Abstract][Full Text] [Related]
10. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women.
Kumru S; Aydin S; Gursu MF; Ozcan Z
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):177-81. PubMed ID: 15140512
[TBL] [Abstract][Full Text] [Related]
11. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
[TBL] [Abstract][Full Text] [Related]
13. Oxidizability of apolipoprotein B-containing lipoproteins, levels of lipid peroxidation products and antioxidants in normal pregnancy.
Sarandöl E; Dirican M; Serdar Z
Arch Gynecol Obstet; 2004 Nov; 270(3):157-60. PubMed ID: 12898147
[TBL] [Abstract][Full Text] [Related]
14. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
15. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
16. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
17. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
18. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase and arylesterase activities in stent restenosis in bare metal stent.
Demirbag R; Sezen Y; Yeşilay AB; Bas M; Yildiz A; Guntekin U; Aksoy N
Coron Artery Dis; 2011 Aug; 22(5):289-93. PubMed ID: 21394024
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]